Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
AJU Pharm Co., Ltd. clinical trials
Part of AJU Holdings Co., Ltd..
The registry lists 19 studies whose lead sponsor is AJU Pharm Co., Ltd.. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 21, 2026.
Keep track of what changes. Save the AJU Pharm Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- Korea, Republic of
- 19
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to AJU Pharm Co., Ltd..
- AJU Pharm Co., Ltd.19 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 19 of 19.
- Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed ConditionsNot yet recruitingNCT07643233Phase 1
- A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State StudyNot yet recruitingNCT07044765Phase 1
- A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy AdultsNot yet recruitingNCT07034781Phase 1
- Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome PatientsRecruitingNCT06291194Phase 3
- The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain SyndromeRecruitingNCT06345014Phase 4
- Efficacy and Safety of AJU-C52 in Essential Hypertension PatientsCompletedNCT06416865Phase 3
- Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fasting ConditionsCompletedNCT07643220Phase 1
- Bioequivalence Study of AJU-R713 and R713R in Healthy Adult VolunteersCompletedNCT07231861Phase 1
- Bioequivalence Study of AJU-C715 and C715R in Healthy Adult VolunteersCompletedNCT07581028Phase 1
- To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDRCompletedNCT07230184Phase 4
- To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy AdultsCompletedNCT07655960Phase 1
- To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy AdultsCompletedNCT06931327Phase 1
- To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy AdultsActive, not recruitingNCT06933459Phase 1
- Efficacy and Safety of AJU-S56 in Dry Eye Syndrome PatientsCompletedNCT06337981Phase 2
- Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus PatientsCompletedNCT06329674Phase 3
- A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy VolunteersStatus unknownNCT05077462Phase 1
- A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy VolunteersStatus unknownNCT05077475Phase 1
- Evaluation of Pharmacokinetics and Safety of AJU-A51 in Healthy AdultsCompletedNCT04972539Phase 1
- The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2CompletedNCT04970940Phase 1